A randomized phase II study of gemcitabine/trastuzumab and gemcitabine/cisplatin/trastuzumab in patients with metastatic breast cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Dec 2017 Biomarkers information updated
- 06 Nov 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 17 Nov 2011 Planned End Date changed from 1 Mar 2008 to 1 Jun 2012 as reported by ClinicalTrials.gov.